The Wong et al. (2022) research investigated how a nurse-led telehealth self-care promotion program affected older individuals living in the community and their quality of life (QoL). The research emphasized the potential advantages of telehealth treatments in improving patient outcomes while not focusing primarily on nutritional therapies. The results showed that telehealth treatments directed by nurses substantially positively impacted older persons’ self-efficacy, depression, and general quality of life. The research results indicate that telehealth treatments may benefit COPD management and general well-being, even if they are not directly connected to lung function and readmission. The Leonard et al. (2021) research looked at how a telemedicine intervention affected noninvasive home ventilation (NIV) in a COPD group in a rural area. The research emphasizes the potential advantages of telemedicine in remote monitoring and treating COPD, even though NIV was the main emphasis. The telemedicine intervention led to better NIV treatment adherence, which may benefit lung function and overall disease management. Healthcare professionals may monitor patient progress, see early indications of exacerbations, and provide prompt treatments by incorporating remote monitoring via telehealth interventions. Thus, remote monitoring and telemedicine may help COPD patients achieve their intended objectives of increased lung function and fewer readmissions.
The impact of post-discharge telemonitoring on 30-day COPD readmissions and death rates was examined by Hamadi et al. in 2020. This research assessed the influence of telehealth services on readmission and death rates in COPD patients without specifically addressing dietary therapy. The findings showed that those hospitals providing post-discharge telemonitoring saw an increase in readmissions but a reduction in 30-day COPD death rates. This research suggests that, despite possible difficulties linked to readmission rates, telemedicine treatments may contribute to lowering mortality and improving patient outcomes. Mohr et al. (2023) conducted a comparative efficacy-matched cohort research to assess the relationship between the start of home telehealth (HT) and healthcare use in veterans with CHF, COPD, or DM. Although dietary treatments were not a primary focus of the trial, it did examine how HT monitoring affected inpatient hospitalizations, ED visits, and death rates. The findings showed that HT start was linked to more ED visits but not a significant change in hospitalizations for individuals with CHF and DM. However, HT start was linked to more excellent all-cause death rates and higher healthcare utilization in people with COPD. This research demonstrates that the particular chronic ailment being treated may impact the efficacy of telemedicine treatments.
The studies that have been evaluated provide light on the possible advantages and difficulties of telehealth therapies in the setting of COPD. The studies show that telehealth treatments, directed by healthcare experts like nurses, may favor patient outcomes, including QoL, self-efficacy, and mortality rates, even when dietary therapies were not explicitly addressed. The need for more research to improve the design, execution, and integration of telehealth therapies in COPD therapy is highlighted by rising ED visits and inconsistent impacts on readmission rates. Including dietary therapies in telehealth programs might provide a more thorough way to meet the unique requirements of COPD patients, improve their lung function, and reduce readmission rates.
A comprehensive review and meta-analysis of telemedicine therapies for COPD in China were undertaken by Liu et al. (2020). The study findings demonstrated that the implementation of telemedicine significantly improved the quality of life for patients with COPD while simultaneously reducing hospitalization rates. This research proves that telehealth treatments help manage COPD, which aligns with the PICOT question’s goal of lowering readmission rates and improving lung function. The changes in plasma amino acid levels in patients with acute exacerbation of COPD (AECOPD) with and without bacterial infection are the main topic of Inoue and Ikeda’s research from 2019. The research emphasizes the significance of comprehending COPD patients’ nutritional status and metabolic changes during exacerbations, even if it does not explicitly address nutritional therapies. According to the research, certain amino acids such as asparagine, citrulline, glutamine, histidine, serine, and threonine might be used as diagnostic indicators to distinguish between bacterial and nonbacterial Acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This highlights the potential value of nutritiona
Struggling with online classes or exams? Get expert help to ace your coursework, assignments, and tests stress-free!